Severe interstitial lung disease following treatment with certolizumab pegol: a case report

Severe interstitial lung disease following treatment with certolizumab pegol: a case report

Bibliographic Details
Main Authors:	Jakob Lager, Ole Hilberg, Anders Løkke, Elisabeth Bendstrup
Format:	Article
Language:	English
Published:	European Respiratory Society 2013-09-01
Series:	European Respiratory Review
Online Access:	http://err.ersjournals.com/content/22/129/414.full.pdf+html

Similar Items

Certolizumab pegol in the treatment of spondyloarthritis
by: Mariusz Korkosz
Published: (2014-09-01)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS
by: Sh. F. Erdes
Published: (2016-02-01)

EFFICACY OF CERTOLIZUMAB PEGOL IN THE TREATMENT OF PSORIATIC ARTHRITIS
by: T. V. Korotaeva, et al.
Published: (2015-10-01)

Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis
by: M Connock, et al.
Published: (2010-10-01)

Certolizumab pegol: new opportunities for treatment of moderate to severe plaque psoriasis
by: A. A. Kubanov, et al.
Published: (2019-12-01)

Certolizumab pegol in therapy for rheumatoid arthritis
by: Galina Viktorovna Lukina, et al.
Published: (2012-06-01)

Certolizumab pegol in treatment of Crohn's disease with perianal lesions
by: I.L. Khalif, et al.
Published: (2018-04-01)

Certolizumab pegol – new option in the treatment of psoriatic arthritis
by: Maria Majdan, et al.
Published: (2014-07-01)

Certolizumab pegol in treatment of Crohn's disease with perianal lesions
by: I L Khalif, et al.
Published: (2018-04-01)

Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol
by: Mehmet Baysal, et al.
Published: (2018-09-01)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF TAKAYASU ARTERITIS: THE FIRST EXPERIENCE AND PROSPECTS
by: P. I. Novikov, et al.
Published: (2018-07-01)

Multifocal tuberculosis on certolizumab pegol in a patient followed for rheumatoid arthritis
by: Emna Hannech, et al.
Published: (2021-06-01)

Emphysema mimicking interstitial lung disease: Two case reports
by: Kasper S. Juhl, et al.
Published: (2015-01-01)

A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis
by: Pablo Coto-Segura, et al.
Published: (2023-09-01)

Clinical characteristics and outcome in patients with antisynthetase syndrome associated interstitial lung disease: a retrospective cohort study
by: Mads Lynge Jensen, et al.
Published: (2019-01-01)

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
by: Ruiz Garcia, V, et al.
Published: (2011)

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
by: Ruiz Garcia, V, et al.
Published: (2014)

Quantitation of certolizumab pegol by validated liquid chromatography methods
by: Clóvis Dervil Appratto Cardoso Júnior, et al.
Published: (2023-11-01)

Experience with long-term use of certolizumab pegol (Cimzia)
by: Karine Arnoldovna Lytkina, et al.
Published: (2013-10-01)

Experience with long-term use of certolizumab pegol (Cimzia)
by: Karine Arnoldovna Lytkina, et al.
Published: (2013-10-01)

Active axial spondyloarthritis: potential role of certolizumab pegol
by: Ranatunga S, et al.
Published: (2014-02-01)

Certolizumab pegol w leczeniu reumatoidalnego zapalenia stawów
by: Piotr Wiland, et al.
Published: (2011-08-01)

Possible relationship between certolizumab pegol and arrhythmias: report of two cases
by: R. Talotta, et al.
Published: (2016-09-01)

Successful treatment of dissecting cellulitis with certolizumab pegol in a pregnant patient
by: Nouf Almuhanna, MD, et al.
Published: (2023-09-01)

QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL
by: Vera Nikolayevna Amirdjanova, et al.
Published: (2012-10-01)

Patient Adherence and Efficacy of Certolizumab Pegol in the Management of Crohn's Disease
by: Wojciech Blonski, et al.
Published: (2012-04-01)

Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practice
by: O V Knyazev, et al.
Published: (2018-06-01)

Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis
by: A. Spadaro, et al.
Published: (2013-07-01)

Certolizumab pegol – Tumor necrosis factor inhibitor for refractory uveitis
by: Yael Sharon, et al.
Published: (2020-06-01)

Complete Spontaneous Regression of Squamous-Cell Lung Cancer: A Case Report
by: Allan Klitgaard, et al.
Published: (2022-06-01)

New treatment possibilities for rheumatoid arthritis: the Russian experience in using certolizumab pegol
by: Dmitry Evgenyevich Karateev, et al.
Published: (2012-04-01)

Successful Certolizumab Pegol Treatment of Chronic Anterior Uveitis Associated with Psoriasis Vulgaris
by: Keiko Yamaguchi, et al.
Published: (2018-12-01)

Spotlight on certolizumab pegol in the treatment of axial spondyloarthritis: efficacy, safety and place in therapy
by: Marin J, et al.
Published: (2018-05-01)

New aspects of the pharmacotherapy of rheumatoid arthritis: a focus on certolizumab pegol
by: Evgeniy L'vovich Nasonov, et al.
Published: (2011-02-01)

Mapping the certolizumab pegol epitope on TNF and comparison with infliximab, adalimumab and etanercept
by: Henry Alistair I, et al.
Published: (2011-11-01)

An evidence-based review of certolizumab pegol in the treatment of active psoriatic arthritis: place in therapy
by: Acosta-Felquer ML, et al.
Published: (2016-03-01)

Pegylation Reduces the Uptake of Certolizumab Pegol by Dendritic Cells and Epitope Presentation to T-Cells
by: Marie de Bourayne, et al.
Published: (2022-02-01)

Prefilled certolizumab pegol (Cimzia&reg;) syringes for self-use in the treatment of rheumatoid arthritis
by: J Rosa, et al.
Published: (2010-08-01)

The efficacy of certolizumab pegol in rheumatoid arthritis assessed by gray scale and power Doppler ultrasonography: case reports
by: José Alexandre Mendonça, et al.
Published: (2019-02-01)

HLA‐C*06:02 allele can influence clinical efficacy of certolizumab pegol?
by: Annunziata Dattola, et al.
Published: (2021-06-01)